ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,653.00
12.50 (0.76%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.50 0.76% 1,653.00 1,654.00 1,655.00 1,655.50 1,634.00 1,638.50 3,990,601 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.83 68.14B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,640.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.14 billion. Gsk has a price to earnings ratio (PE ratio) of 13.83.

Gsk Share Discussion Threads

Showing 21426 to 21449 of 33100 messages
Chat Pages: Latest  868  867  866  865  864  863  862  861  860  859  858  857  Older
DateSubjectAuthorDiscuss
15/6/2020
09:30
ViiV Healthcare on Friday said the US Food & Drug Administration has approved Tivicay PD tablets, an HIV drug, for oral suspension.


Here is the 'news':


ViiV is a specialist human immunodeficiency virus company, majority-owned by GlaxoSmithKline PLC, with Pfizer Inc and Shionogi Ltd as shareholders.

Tivicay PD tablets are used in combination with other antiretroviral agents for the treatment of HIV type 1 infection in paediatric patients aged at least four weeks and weighing at least 3 kilograms, as well as an extended indication to expand the use of the already approved Tivicay tablet in paediatric HIV patients weighing 20 kilograms and above.

The FDA approval is based on data from the ongoing P1093 and Odyssey studies.

"We now need to continue our efforts to ensure this new dispersible formulation is available to children who need it around the world, in line with our mission to leave no person living with HIV behind," said ViiV Chief Executive Deborah Waterhouse.

tradermichael
15/6/2020
09:06
Perhaps if RNS was offering 1 free toilet roll with every 1k shares, The affect may be positive !!
roybel
15/6/2020
09:04
What RNS ? Have I missed something ?
rik shaw
15/6/2020
08:17
Great rns doesn't stop gsk getting hammered!
spoole5
15/6/2020
07:57
Great rns today, FTSE looks ugly, pharmaceuticals the place to be.
montyhedge
13/6/2020
23:40
Thanks... As it would help if people read more than one post, especially if they have the tendancy to be rude.
gateside
13/6/2020
16:05
GtG - I suggest that you read post 21440 and then apologise to Gateside!
ianood
12/6/2020
16:47
Gateside.

I'm guessing you struggle to read


Monty earlier today


"montyhedge12
Post 21442 of 21446
I have GSK in an Isa just stating a fact"

geckotheglorious
12/6/2020
15:23
Monty have you not heard of an ISA?Tax free!
gateside
12/6/2020
14:19
Astra completely transformed itself, GSK could do the same.If CEO gets its right selling off the right subsidiaries, then investing in research 2500p in a few years time.
montyhedge
12/6/2020
11:06
Just ignore him Jadetic or filter him (I've had him on filter for years). I'm guessing its just random price forecasts that he's plucked out of the air depending whether he's be 50p a point long or short on IG. If he's posted something actually worth reading by all means repost it and I'll acknowledge my error.
dr biotech
12/6/2020
10:54
If CEO can get it going like AstraZenecca then they will be back to 2200p, like 20 years ago when they took over Smith Kline Beecham.
montyhedge
12/6/2020
10:06
I have GSK in an Isa just stating a fact.
montyhedge
12/6/2020
09:16
Monty, why don’t you just leave this site? If you think GSK is not worth bothering with just disappear—I won’t complain.
jadeticl3
12/6/2020
08:50
Paid tax income tax on that, no growth in 20 years, lol
montyhedge
12/6/2020
08:42
Monty - a few figures to help you.Even if the share price does not change in next 20 years, if dividends are reinvested with today's yield of 5% an investment of £10000 would turn into £27000.The beauty of compound interest!
gateside
12/6/2020
08:31
Will eventually be gobbled up if share underperformance continues, until then just collect the divis!
spoole5
12/6/2020
07:45
Shareprice below what it was 20 years ago, will be the same for the next 20 years, no growth, but you do get a piddling dividend,
montyhedge
11/6/2020
21:00
Below 1600p it yields above 5% that's why.
gateside
11/6/2020
19:16
Agree MH, world is waking up that all is not rosey. I`ve been thinking for a while that the markets are too high given the dire outlook of the macro economy.
dandu69
11/6/2020
18:53
Dow looking ugly, GSK 1565p in the morning.
montyhedge
11/6/2020
15:58
Could be tempted to add a few at 1600p
gateside
11/6/2020
14:54
Wrong thread. Toodle pip.
daveboy1
11/6/2020
14:48
TM every thing is caught in the Corona trap,whether the markets go up or down it is not relevant.
abdullla
Chat Pages: Latest  868  867  866  865  864  863  862  861  860  859  858  857  Older

Your Recent History

Delayed Upgrade Clock